NO155842C - Analogifremgangsmaate ved fremstilling av terapeutiske aktive 2-beta-d-ribofuranosylselenazol-4-carboxamider. - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutiske aktive 2-beta-d-ribofuranosylselenazol-4-carboxamider.

Info

Publication number
NO155842C
NO155842C NO831012A NO831012A NO155842C NO 155842 C NO155842 C NO 155842C NO 831012 A NO831012 A NO 831012A NO 831012 A NO831012 A NO 831012A NO 155842 C NO155842 C NO 155842C
Authority
NO
Norway
Prior art keywords
ribofuranosylselenazole
carboxamides
beta
preparation
therapeutic active
Prior art date
Application number
NO831012A
Other languages
English (en)
Other versions
NO831012L (no
NO155842B (no
Inventor
Roland Kenith Robins
Prem Chandra Srivastava
Original Assignee
Univ Brigham Young
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Brigham Young filed Critical Univ Brigham Young
Publication of NO831012L publication Critical patent/NO831012L/no
Publication of NO155842B publication Critical patent/NO155842B/no
Publication of NO155842C publication Critical patent/NO155842C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D421/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms
    • C07D421/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms containing two hetero rings
    • C07D421/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/20—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
NO831012A 1982-03-23 1983-03-22 Analogifremgangsmaate ved fremstilling av terapeutiske aktive 2-beta-d-ribofuranosylselenazol-4-carboxamider. NO155842C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36096882A 1982-03-23 1982-03-23
US06/465,221 US4531001A (en) 1982-03-23 1983-02-15 2-β-D-ribofuranosylselenazole-4-carboxamide compounds

Publications (3)

Publication Number Publication Date
NO831012L NO831012L (no) 1983-09-26
NO155842B NO155842B (no) 1987-03-02
NO155842C true NO155842C (no) 1987-06-10

Family

ID=27001098

Family Applications (1)

Application Number Title Priority Date Filing Date
NO831012A NO155842C (no) 1982-03-23 1983-03-22 Analogifremgangsmaate ved fremstilling av terapeutiske aktive 2-beta-d-ribofuranosylselenazol-4-carboxamider.

Country Status (14)

Country Link
US (1) US4531001A (no)
EP (1) EP0089678B1 (no)
KR (1) KR880001869B1 (no)
AU (1) AU553665B2 (no)
CA (1) CA1209986A (no)
DE (1) DE3366378D1 (no)
DK (2) DK167765B1 (no)
ES (5) ES520826A0 (no)
FI (1) FI76574C (no)
GR (1) GR78301B (no)
IE (1) IE54520B1 (no)
NO (1) NO155842C (no)
NZ (1) NZ203649A (no)
PT (1) PT76426B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4619996A (en) * 1984-07-09 1986-10-28 Warner-Lambert Company Process for preparing 2-β-D-ribofuranosylselenazole-4-carboxamide
US4801698A (en) * 1986-08-15 1989-01-31 Warner-Lambert Company Process for preparing diaminopyrimido(4,5-d)pyrimidine glycoside and glycotide
US5438131A (en) * 1992-09-16 1995-08-01 Bergstrom; Donald E. 3-nitropyrrole nucleoside
GB9307043D0 (en) * 1993-04-05 1993-05-26 Norsk Hydro As Chemical compounds
AU5298096A (en) * 1995-02-17 1996-09-11 Icn Pharmaceuticals, Inc. Procedures for obtaining ribo-c-nucleosides
NZ500831A (en) * 1997-06-30 2001-06-29 Icn Pharmaceuticals Method of producing tiazofurin and other C-nucleosides using a single step process wherein the cyano sugar group is converted into thiocarboxamide and subsequently condensed to form an azole ring

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3423399A (en) * 1966-06-09 1969-01-21 Takeda Chemical Industries Ltd Method for the production of 5'-ribonucleotide
US3984396A (en) * 1971-06-01 1976-10-05 Icn Pharmaceuticals, Inc. 1-(β,-D-ribofuranosyl)-1,2,4-triazole acid esters
US3798209A (en) * 1971-06-01 1974-03-19 Icn Pharmaceuticals 1,2,4-triazole nucleosides

Also Published As

Publication number Publication date
ES8504795A1 (es) 1985-04-16
CA1209986A (en) 1986-08-19
DK25093D0 (da) 1993-03-08
DK25093A (da) 1993-03-08
ES527279A0 (es) 1985-10-01
ES8404373A1 (es) 1984-05-01
EP0089678B1 (en) 1986-09-24
ES527277A0 (es) 1985-10-01
NO831012L (no) 1983-09-26
NZ203649A (en) 1985-02-28
EP0089678A1 (en) 1983-09-28
FI830941A0 (fi) 1983-03-22
IE830580L (en) 1983-09-23
KR880001869B1 (ko) 1988-09-23
FI76574C (fi) 1988-11-10
DK129983D0 (da) 1983-03-22
PT76426A (en) 1983-04-01
ES8600321A1 (es) 1985-10-01
DE3366378D1 (en) 1986-10-30
NO155842B (no) 1987-03-02
FI76574B (fi) 1988-07-29
GR78301B (no) 1984-09-26
AU553665B2 (en) 1986-07-24
FI830941L (fi) 1983-09-24
DK129983A (da) 1983-09-24
AU1269383A (en) 1983-09-29
DK172165B1 (da) 1997-12-08
ES8600323A1 (es) 1985-10-01
US4531001A (en) 1985-07-23
ES527278A0 (es) 1985-04-16
PT76426B (en) 1986-02-04
ES527276A0 (es) 1985-10-01
DK167765B1 (da) 1993-12-13
IE54520B1 (en) 1989-11-08
ES8600322A1 (es) 1985-10-01
ES520826A0 (es) 1984-05-01
KR840004126A (ko) 1984-10-06

Similar Documents

Publication Publication Date Title
NO161002C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive polypeptider.
NO160521C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 13alfa- alkylgonaner.
NO156785C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklobutan-derivater.
NO150760C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminotiazoler.
NO163285C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive steroider.
NO810675L (no) Fremgangsmaate ved fremstilling av terapeutisk aktive tetrazolderivater.
NO161317C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oksikamer.
NO163693C (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser av platina.
NO154492C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme forbindelser.
NO158460C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO814055L (no) Fremgangsmaate ved fremstilling av terapeutisk aktive thienopyridinonderivater
NO159528C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive aminoguanidinderivater.
NO157976C (no) Analogifremgangsm te ved fremstilling av terapeutisk aktive 3-fenoxy-1-azetidincarboxamider.
NO165400C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive cefemforbindelser.
NO162817C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 4-aryl-4-piperidin-carbinoler.
NO880667L (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylpiperazinyl-alkylen-fenyl-heterocykliske forbindelser.
NO811346L (no) Fremgangsmaate ved fremstilling av terapeutisk aktive adenosin-derivater.
NO873680D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive sulfonamido-etyl-forbindelser.
NO159090C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater.
NO164899C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylindolforbindelser.
NO158800C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indenderivater.
NO156167C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indolinon-derivater.
NO163570C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive acylaminomitosaner.
NO162188C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinoliner.
NO155842C (no) Analogifremgangsmaate ved fremstilling av terapeutiske aktive 2-beta-d-ribofuranosylselenazol-4-carboxamider.